305 related articles for article (PubMed ID: 21087210)
21. Small-molecule inhibitors of PDK1.
Peifer C; Alessi DR
ChemMedChem; 2008 Dec; 3(12):1810-38. PubMed ID: 18972468
[TBL] [Abstract][Full Text] [Related]
22. Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252.
Balendran A; Currie R; Armstrong CG; Avruch J; Alessi DR
J Biol Chem; 1999 Dec; 274(52):37400-6. PubMed ID: 10601311
[TBL] [Abstract][Full Text] [Related]
23. A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Czeta (PKCzeta ) and PKC-related kinase 2 by PDK1.
Balendran A; Biondi RM; Cheung PC; Casamayor A; Deak M; Alessi DR
J Biol Chem; 2000 Jul; 275(27):20806-13. PubMed ID: 10764742
[TBL] [Abstract][Full Text] [Related]
24. Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells.
Baxi SM; Tan W; Murphy ST; Smeal T; Yin MJ
PLoS One; 2012; 7(10):e48402. PubMed ID: 23119004
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells.
Tamgüney T; Zhang C; Fiedler D; Shokat K; Stokoe D
Exp Cell Res; 2008 Jul; 314(11-12):2299-312. PubMed ID: 18514190
[TBL] [Abstract][Full Text] [Related]
26. The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: possible role of metalloproteinases.
Alcántara-Hernández R; Hernández-Méndez A; García-Sáinz JA
Eur J Pharmacol; 2014 Oct; 740():88-96. PubMed ID: 25016091
[TBL] [Abstract][Full Text] [Related]
27. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
García-Martínez JM; Alessi DR
Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
[TBL] [Abstract][Full Text] [Related]
28. Phosphoinositide-dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophils.
Sturm EM; Parzmair GP; Radnai B; Frei RB; Sturm GJ; Hammer A; Schuligoi R; Lippe IT; Heinemann A
Eur J Immunol; 2015 May; 45(5):1548-59. PubMed ID: 25645675
[TBL] [Abstract][Full Text] [Related]
29. S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions.
Jiang Q; Zhang X; Dai X; Han S; Wu X; Wang L; Wei W; Zhang N; Xie W; Guo J
Nat Commun; 2022 Mar; 13(1):1548. PubMed ID: 35318320
[TBL] [Abstract][Full Text] [Related]
30. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
[TBL] [Abstract][Full Text] [Related]
31. Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.
Feldman RI; Wu JM; Polokoff MA; Kochanny MJ; Dinter H; Zhu D; Biroc SL; Alicke B; Bryant J; Yuan S; Buckman BO; Lentz D; Ferrer M; Whitlow M; Adler M; Finster S; Chang Z; Arnaiz DO
J Biol Chem; 2005 May; 280(20):19867-74. PubMed ID: 15772071
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum- and glucocorticoid-induced protein kinase in vivo.
Lizcano JM; Deak M; Morrice N; Kieloch A; Hastie CJ; Dong L; Schutkowski M; Reimer U; Alessi DR
J Biol Chem; 2002 Aug; 277(31):27839-49. PubMed ID: 12023960
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1.
Wick MJ; Dong LQ; Riojas RA; Ramos FJ; Liu F
J Biol Chem; 2000 Dec; 275(51):40400-6. PubMed ID: 11006271
[TBL] [Abstract][Full Text] [Related]
34. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Kobayashi T; Cohen P
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):319-28. PubMed ID: 10191262
[TBL] [Abstract][Full Text] [Related]
35. Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors.
Chen T; Sorna V; Choi S; Call L; Bearss J; Carpenter K; Warner SL; Sharma S; Bearss DJ; Vankayalapati H
Bioorg Med Chem Lett; 2017 Dec; 27(24):5473-5480. PubMed ID: 29150397
[TBL] [Abstract][Full Text] [Related]
36. The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB.
Biondi RM; Kieloch A; Currie RA; Deak M; Alessi DR
EMBO J; 2001 Aug; 20(16):4380-90. PubMed ID: 11500365
[TBL] [Abstract][Full Text] [Related]
37. Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling.
Thimmaiah KN; Easton JB; Germain GS; Morton CL; Kamath S; Buolamwini JK; Houghton PJ
J Biol Chem; 2005 Sep; 280(36):31924-35. PubMed ID: 16009706
[TBL] [Abstract][Full Text] [Related]
38. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.
Frödin M; Jensen CJ; Merienne K; Gammeltoft S
EMBO J; 2000 Jun; 19(12):2924-34. PubMed ID: 10856237
[TBL] [Abstract][Full Text] [Related]
39. Chemotactic activation of Dictyostelium AGC-family kinases AKT and PKBR1 requires separate but coordinated functions of PDK1 and TORC2.
Liao XH; Buggey J; Kimmel AR
J Cell Sci; 2010 Mar; 123(Pt 6):983-92. PubMed ID: 20200230
[TBL] [Abstract][Full Text] [Related]
40. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation.
Frödin M; Antal TL; Dümmler BA; Jensen CJ; Deak M; Gammeltoft S; Biondi RM
EMBO J; 2002 Oct; 21(20):5396-407. PubMed ID: 12374740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
